Characterization of lentiviral pseudotypes with influenza H5N1 hemagglutinin and their performance in neutralization assays

Journal of Virological Methods

Volumn 165, Issue 2, 2010, Pages 305-310

  Wang, Wei ^a   Xie, Hang ^a   Ye, Zhiping ^a   Vassell, Russell ^a   Weiss, Carol D ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Hemagglutinin; Influenza; Neutralization; Pseudotype

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ;

ARTICLE; DILUTION; HEMAGGLUTINATION INHIBITION; INFLUENZA VIRUS A H5N1; LENTIVIRINAE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PSEUDOTYPING; VIRUS GENE; VIRUS INFECTIVITY; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; LENTIVIRUS; NEUTRALIZATION TESTS; SHEEP;

EID: 77951023285     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2010.02.009     Document Type: Article

References (21)

1. Alberini I., Del Tordello E., Fasolo A., Temperton N.J., Galli G., Gentile C., Montomoli E., Hilbert A.K., Banzhoff A., Del Giudice G., Donnelly J.J., Rappuoli R., Capecchi B. Pseudoparticle neutralization is a reliable assay to measure immunity and cross-reactivity to H5N1 influenza viruses. Vaccine 2009, 27:5998-6003.
2. Andrewes C.H., Elford W.J. Observations on anti-phage sera. I. " The percentage law" Br. J. Exp. Pathol. 1933, 14:367-376.
3. Bottcher E., Matrosovich T., Beyerle M., Klenk H.D., Garten W., Matrosovich M. Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. J. Virol. 2006, 80:9896-9898.
4. Burnet F.M., Keogh E.V., Lush D. The immunological reactions of the filterable viruses. Aust. J. Exp. Biol. Med. Sci. 1937, 15:227-368.
5. Caton A.J., Brownlee G.G., Yewdell J.W., Gerhard W. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 1982, 31:417-427.
6. Chen B.J., Leser G.P., Morita E., Lamb R.A. Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles. J. Virol. 2007, 81:7111-7123.
7. Ekiert D.C., Bhabha G., Elsliger M.A., Friesen R.H., Jongeneelen M., Throsby M., Goudsmit J., Wilson I.A. Antibody recognition of a highly conserved influenza virus epitope. Science 2009, 324:246-251.
8. Klasse P.J., Sattentau Q.J. Occupancy and mechanism in antibody-mediated neutralization of animal viruses. J. Gen. Virol. 2002, 83:2091-2108.
9. Kong W.P., Hood C., Yang Z.Y., Wei C.J., Xu L., Garcia-Sastre A., Tumpey T.M., Nabel G.J. Protective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccination. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:15987-15991.
10. Li S., Liu C., Klimov A., Subbarao K., Perdue M.L., Mo D., Ji Y., Woods L., Hietala S., Bryant M. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses. J. Infect. Dis. 1999, 179:1132-1138.
11. Nefkens I., Garcia J.M., Ling C.S., Lagarde N., Nicholls J., Tang D.J., Peiris M., Buchy P., Altmeyer R. Hemagglutinin pseudotyped lentiviral particles: characterization of a new method for avian H5N1 influenza sero-diagnosis. J. Clin. Virol. 2007, 39:27-33.
12. Niwa H., Yamamura K., Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991, 108:193-199.
13. Oh S., Selleck P., Temperton N.J., Chan P.K., Capecchi B., Manavis J., Higgins G., Burrell C.J., Kok T. Neutralizing monoclonal antibodies to different clades of influenza A H5N1 viruses. J. Virol. Methods 2009, 157:161-167.
14. Skehel J.J., Wiley D.C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 2000, 69:531-569.
15. Stephenson I., Heath A., Major D., Newman R.W., Hoschler K., Junzi W., Katz J.M., Weir J.P., Zambon M.C., Wood J.M. Reproducibility of serologic assays for influenza virus A (H5N1). Emerg. Infect. Dis. 2009, 15:1252-1259.
16. Stephenson I., Wood J.M., Nicholson K.G., Charlett A., Zambon M.C. Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine. Virus Res. 2004, 103:91-95.
17. Subbarao K., Chen H., Swayne D., Mingay L., Fodor E., Brownlee G., Xu X., Lu X., Katz J., Cox N., Matsuoka Y. Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics. Virology 2003, 305:192-200.
18. Temperton N.J., Hoschler K., Major D., Nicolson C., Manvell R., Hien V.M., Ha D.Q., Jong M.D., Zambon M., Takeuchi Y., Weiss R.A. A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies. Influenza Other Respir. Viruses 2007, 10.1111/j.1750-2659.2007.00016.x.
19. Wang W., Butler E.N., Veguilla V., Vassell R., Thomas J.T., Moos M., Ye Z., Hancock K., Weiss C.D. Establishment of retroviral pseudotypes with influenza hemagglutinins from H1, H3, and H5 subtypes for sensitive and specific detection of neutralizing antibodies. J. Virol. Methods 2008, 153:111-119.
20. WHO Assays for neutralizing antibody to influenza viruses. Report of an informal scientific workshop, Dresden, 18-19 March 2003. Wkly. Epidemiol. Rec. 2003, 78:290-293.
21. Wiley D.C., Skehel J.J. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu. Rev. Biochem. 1987, 56:365-394.